Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma.
Saved in:
| Title: | Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma. |
|---|---|
| Authors: | Su C; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Kent CL; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Pierpoint M; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Floyd W; MD Anderson Cancer Center, Houston, TX, USA., Luo L; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Wiliams NT; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Ma Y; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Peng B; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Lazarides AL; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Subramanian A; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Himes JE; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Perez VM; Tempus AI, Inc., Durham, NC, USA., Hernansaiz-Ballesteros RD; Tempus AI, Inc., Durham, NC, USA., Roche KE; Tempus AI, Inc., Durham, NC, USA.; QuantBio, LLC., Durham, NC, USA., Modliszewski JL; QuantBio, LLC., Durham, NC, USA., Selitsky SR; Tempus AI, Inc., Durham, NC, USA.; QuantBio, LLC., Durham, NC, USA., Mari Shinohara; Department of Immunology, Duke University, Durham, NC, USA., Wisdom AJ; Department of Radiation Oncology, Harvard University, Cambridge, MA, USA., Moding EJ; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Mowery YM; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.; MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, USA., Kirsch DG; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2024 Jan 04. Date of Electronic Publication: 2024 Jan 04. |
| Publication Type: | Preprint; Journal Article |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38260522 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Su+C%22">Su C</searchLink>; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kent+CL%22">Kent CL</searchLink>; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Pierpoint+M%22">Pierpoint M</searchLink>; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Floyd+W%22">Floyd W</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Luo+L%22">Luo L</searchLink>; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Wiliams+NT%22">Wiliams NT</searchLink>; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ma+Y%22">Ma Y</searchLink>; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Peng+B%22">Peng B</searchLink>; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Lazarides+AL%22">Lazarides AL</searchLink>; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Subramanian+A%22">Subramanian A</searchLink>; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Himes+JE%22">Himes JE</searchLink>; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Perez+VM%22">Perez VM</searchLink>; Tempus AI, Inc., Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hernansaiz-Ballesteros+RD%22">Hernansaiz-Ballesteros RD</searchLink>; Tempus AI, Inc., Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Roche+KE%22">Roche KE</searchLink>; Tempus AI, Inc., Durham, NC, USA.; QuantBio, LLC., Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Modliszewski+JL%22">Modliszewski JL</searchLink>; QuantBio, LLC., Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Selitsky+SR%22">Selitsky SR</searchLink>; Tempus AI, Inc., Durham, NC, USA.; QuantBio, LLC., Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Mari+Shinohara%22">Mari Shinohara</searchLink>; Department of Immunology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Wisdom+AJ%22">Wisdom AJ</searchLink>; Department of Radiation Oncology, Harvard University, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moding+EJ%22">Moding EJ</searchLink>; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mowery+YM%22">Mowery YM</searchLink>; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.; MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kirsch+DG%22">Kirsch DG</searchLink>; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2024 Jan 04. <i>Date of Electronic Publication: </i>2024 Jan 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Preprint; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38260522 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/2024.01.03.573968 Languages: – Code: eng Text: English Titles: – TitleFull: Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Su C – PersonEntity: Name: NameFull: Kent CL – PersonEntity: Name: NameFull: Pierpoint M – PersonEntity: Name: NameFull: Floyd W – PersonEntity: Name: NameFull: Luo L – PersonEntity: Name: NameFull: Wiliams NT – PersonEntity: Name: NameFull: Ma Y – PersonEntity: Name: NameFull: Peng B – PersonEntity: Name: NameFull: Lazarides AL – PersonEntity: Name: NameFull: Subramanian A – PersonEntity: Name: NameFull: Himes JE – PersonEntity: Name: NameFull: Perez VM – PersonEntity: Name: NameFull: Hernansaiz-Ballesteros RD – PersonEntity: Name: NameFull: Roche KE – PersonEntity: Name: NameFull: Modliszewski JL – PersonEntity: Name: NameFull: Selitsky SR – PersonEntity: Name: NameFull: Mari Shinohara – PersonEntity: Name: NameFull: Wisdom AJ – PersonEntity: Name: NameFull: Moding EJ – PersonEntity: Name: NameFull: Mowery YM – PersonEntity: Name: NameFull: Kirsch DG IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 01 Text: 2024 Jan 04 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |
